Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Cullinan Oncology, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results Phase 3 first-line study of zipalertinib in EGFR exon 20 insertion mutation non-small-cell lung cancer patients open to enrollment Initial monotherapy clinical data for CLN-619 presented at ASCO 2023 Annual Meeting; initiated monotherapy expansion cohorts in endometrial and cervical cancers First patient dosed in Phase 1study of CLN-978 in relapsed/refractory B Cell non-Hodgkin lymphoma Cash and investment position of $512.1 million as of June 30, 2023 continues to provide runway into 2026 CAMBRIDGE, Mass., August 10, 2023 -- Cullinan Oncology, Inc. a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today reported on recent and upcoming business highlights and an..."
05/25/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Cullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023"
05/11/2023 8-K Quarterly results
Docs: "Cullinan Oncology Provides Corporate Update and Reports First Quarter 2023 Financial Results"
03/09/2023 8-K Quarterly results
Docs: "Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results"
01/19/2023 8-K Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock",
"Exchange Agreement, by and among Cullinan Oncology, Inc. and the Stockholders named therein"
10/25/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
06/27/2022 8-K Quarterly results
06/24/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/17/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
12/29/2021 8-K Quarterly results
12/16/2021 8-K Quarterly results
11/09/2021 8-K Quarterly results
Docs: "Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2021 Financial Results"
10/18/2021 8-K Quarterly results
08/10/2021 8-K Quarterly results
07/01/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
06/04/2021 8-K Quarterly results
05/21/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
Docs: "Cullinan Oncology Reports First Quarter 2021 Financial Results"
03/30/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Cullinan Oncology Reports Full Year 2020 Financial Results and Business Highlights"
02/26/2021 8-K Quarterly results
02/22/2021 8-K Quarterly results
01/13/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy